CD19 and plasma cell myeloma: In all patients, we found, that CD19 CAR-T eliminated CD19low myeloma cells, including CD19low myeloma cells from patients M017 and M013, that expressed on average 64 ± 8 and 93 ± 10 CD19 molecules per cell, respectively (Supplementary Fig. 4).